UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example PackagedProductDefinition: SimvastatinBluefish-80mg-Tablet-SE-BS-PPD

Generated Narrative: PackagedProductDefinition SimvastatinBluefish-80mg-Tablet-SE-BS-PPD

identifier: http://ema.europa.eu/example/pcid/?ngen-9?

packageFor: MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100002566-00026680,http://ema.europa.eu/fhir/eurdId#2709; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Film-coated tablet; indication = Hypercholesterolaemia Treatment of primary hypercholesterolaemia or mixed dyslipidaemia, as an adjunct to diet, when response to diet and other non-pharmacological treatments (such as exercise, weight reduction) is inadequate. Treatment of homozygous familial hypercholesterolaemia (HoFH) as an adjunct to diet and other lipid-lowering treatments (e.g. LDL-apheresis) or if such treatments are not appropriate. Cardiovascular prevention Reduction of cardiovascular mortality and morbidity in patients with manifest atherosclerotic cardiovascular disease or diabetes mellitus, with either normal or increased cholesterol levels, as an adjunct to correction of other risk factors and other cardioprotective therapy (see section 5.1).; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = simvastatin

containedItemQuantity: 100 Tablet (Details: 200000000014 code200000002152 = '200000002152')

description:

Blister, 100 tablet

MarketingStatuses

-CountryStatus
*Kingdom of SwedenMarketed

packaging

type: Box

quantity: 1

material: Cardboard

packaging